SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " utica " 445 found 🔀 AI-powered Shuffle
A taste of Carnevale celebrated in Utica
Carnevale 2026 was hosted by the Italian Heritage Club of the Mohawk Valley and was held in the gymnasium of the St. Mary of Mount Carmel/Blessed Sacrament Parish on Catherine Street. Several dozen children decorated their own Carnevale masks and celebrated the Italian Carnevale traditions, famous in Venice.
New Expedition 74 Foursome Kicks off Science, Gets Used to Space
Vein scans and pharmaceutical research topped the science schedule aboard the International Space Station on Wednesday. The Expedition 74 crew rounded out the day with Dragon cargo transfers, lab familiarization activities, and life support maintenance duties.
Vanderbilt Health remembers C. Leon Partain, former chair of Radiology
Clarence Leon Partain, MD, PhD, professor emeritus of Radiology and Radiological Sciences, whose work in nuclear medicine and magnetic resonance imaging helped shape the field of academic radiology, died Jan. 28 in Brentwood, Tennessee. He was 85. After beginning his career as a nuclear engineer at Oak Ridge National Laboratory and as faculty at the University of Missouri and the University of North Carolina, Dr. Partain joined the ranks at Vanderbilt Radiology in 1980 and was promoted to professor in 1984. He later became the first Carol D. and Henry P. Pendergrass Professor of Radiology and Radiological Sciences and chair of the department (1992-2000), and subsequently the director of the Center for Imaging Research. Shortly after arriving in Nashville, Dr. Partain began to lead Vanderbilt Radiology’s nuclear medicine division. He remained in this role until he was named the department chair. Dr. Partain specialized in multiple fields, including nuclear medicine, magnetic resonance imaging and positron emission tomography. Following his time as chair, Dr. Partain shifted his focus to research and spent time working clinically with radiology’s chest imaging section. In 2015, he retired and was honored for his years of service and named as emeritus faculty. Dr. Partain also held an appointment as professor of Biomedical Engineering. A Tennessee native, Dr. Partain was born in Memphis and later graduated from high school in Clarksville. He then received his BS in nuclear engineering from the University of Tennessee, his MS and PhD in nuclear engineering from Purdue University and his MD from Washington University. He completed his residency training in diagnostic radiology and nuclear medicine at the University of North Carolina. Dr. Partain was clinically trained and certified in diagnostic radiology and nuclear radiology by the American Board of Radiology (ABR) and the American Board of Nuclear Medicine. Throughout his career, Dr. Partain contributed to the growth of Vanderbilt Radiology and received many academic and research accolades across the specialty through various associations. During his time leading the department, clinical studies increased from 180,000 to 260,000 cases per year, emerging technological imaging equipment expanded the department’s capabilities, and units for angiography and fluoroscopy were added to the tool kit. The department also expanded its footprint with outpatient imaging in Nashville, Bedford County and more. Research continued to expand with continued growth in scientific findings and millions in grant funding for radiopharmaceuticals, functional MRI, nuclear medicine, X-ray, ultrasound and more. Dr. Partain is celebrated for being instrumental in bringing the first MRI and PET/CT machines to the Medical Center. His efforts helped build Vanderbilt Radiology’s prestige in the world of academics and research both nationally and internationally. His society affiliations included the American College of Radiology, the American College of Nuclear Medicine, and the International Society of Magnetic Resonance in Medicine (ISMRM). He served as president of the Radiological Research Alliance of the Association of Academic Radiologists and has held executive roles as a member of many radiological society boards. Dr. Partain was editor-in-chief of the Journal of Magnetic Resonance Imaging from 2000 to 2013 and a member of the editorial boards of Magnetic Resonance in Medicine, Magnetic Resonance Imaging, the American Journal of Roentgenology, Academic Radiology, the Journal of Nuclear Medicine and Investigative Radiology. He has authored/co-authored/edited six textbooks, including one of the first comprehensive textbooks on MRI, “Nuclear Magnetic Resonance (NMR) Imaging.” Dr. Partain has also authored/co-authored/edited approximately 100-plus book chapters and 200-plus journal articles. In 2000, Dr. Partain received the Distinguished Service Award from the ABR. In 2014, he received the Distinguished Service Award from the ISMRM. In 2016, he received the Alumni Achievement Award from Washington University for his “contributions to advance the fields of nuclear medicine and medical imaging.” Dr. Partain served the ABR as an examiner for 20 years, the Accreditation Council for Graduate Medical Education as a member of the Nuclear Medicine Residency Review Committee, and Vanderbilt University School of Medicine in multiple capacities. A devout Baptist deacon and man of committed faith, he is survived by his wife of 62 years, Judy; children, David (Rebecca), Teri (Bland), and Amy; brother, Larry (Deb); brother-in-law, Tom (Cathy); grandchildren, Sarah (Brandon), Amy, Luke, Tucker, Alex, Ryan and Jake; cousins and a host of nieces and nephews. Vanderbilt Health is grateful to Dr. Partain for his decades of service and major contributions to clinical and research imaging.
Morgan Stanley Maintains Equal Weight on Phibro Animal Health Corporation (PAHC), Cites Margin Expansion
Phibro Animal Health Corporation (NASDAQ:PAHC) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. The seventh stock on our list of cheap pharmaceutical stocks is Phibro Animal Health Corporation (NASDAQ:PAHC). TheFly reported on February 6 that Morgan Stanley increased its price target on PAHC to $49 from $45 and maintained an Equal Weight rating. […]
Utica Event Promotes Hands-Only CPR for Cardiac Emergencies
Fans at Adirondack Bank Center learned about the importance of hands-only CPR during the Utica City Football Club game against the Saint Louis Ambush.
5 Years Strong: An Italian-Style Coffee Spot in Utica Keeps Brewing
A local coffee shop owner is celebrating five years in business.
Scientists Discovered An Organism That Can Become Two Different Life Forms
Knowing which genes are responsible for the transformations could help with developing antifungal treatments, and may have other pharmaceutical and industrial applications.
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune and inflammatory diseases, today announced that Lucinda Warren, who has served as Cue Biopharma’s chief business officer (CBO) since September 2024, has been appointed chief financial and business officer (CFBO) effective February 9, 2026
Gov. Lujan Grisham named to 2026 TIME100 Health list
Lujan Grisham joins federal health care officials, pharmaceutical CEOs, scientists, researchers, actors and performers on the list.
Gov. Michelle Lujan Grisham named on the 2026 TIME100 Health list
Lujan Grisham joins federal health care officials, pharmaceutical CEOs, scientists, researchers, actors and performers on the list.
Innovation District hosts industry-informed life science skills course to support Virginia’s growing workforce needs
Throughout Virginia, the life sciences sector is gaining momentum as major pharmaceutical companies invest billions in new facilities and operations. As a result, employers need to find people who can step into laboratory and manufacturing roles right away. George Mason University's Innovation District is meeting the demand.
$585,100 Park Upgrades Coming to West Utica
West Utica parks are getting a major upgrade with new playground equipment, resurfaced courts and more shade for families.
Health Agency Refers Knockoff GLP-1 Provider Hims & Hers to Justice Department
The FDA said it would take “decisive steps” to restrict nonapproved drugs that use GLP-1 active pharmaceutical ingredients.
New recall includes nearly 23K bottles of triglycerides drug used to treat heart disease
New Jersey-based Zydus Pharmaceuticals has recalled nearly 23,000 bottles of its icosapent ethyl capsules due to leakage issues that may have weakened their effectiveness.
'Rent' and 'Star Trek' Star to Speak in Utica
A Broadway and screen star will appear for a special event in Utica.
DHL Health Logistics Singapore Expands Capabilities to Elevate Life Science & Healthcare Logistics
DHL Group has announced the expansion of its life sciences arm—DHL Health Logistics—with the development of a €10 million Pharmaceutical Hub in Singapore. This investment bolsters regional Life Sciences and Healthcare (LSHC) infrastructure.
RFK Jr. is now a wellness guru for Republicans in Washington
Conservatives in the capital are taking up the health secretary’s advice, eating their vegetables and eschewing pharmaceuticals.
Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficiency Disorder in Mainland China
SHANGHAI, February 01, 2026--GAH and Tenacia announce a China commercialization partnership for ZTALMY, the first approved therapy for CDKL5 deficiency disorder.
MVCC Board of Trustees to meet Tuesday, January 20
UTICA — A meeting of the Mohawk Valley Community College Board of Trustees will take place at 4 p.m. on Tuesday, Jan. 20, on the Utica Campus in the Stetson
Explore Utica Zoo's Snowshoe Trails
Snow shoe rentals are a popular winter activity at the Utica Zoo.
Tanzania eyes East Africa’s pharmaceutical hub crown {Business Africa}
Tanzania is betting on local drug manufacturing to reduce imports and become East Africa’s pharmaceutical hub and we find out how Africa's private sector is fixing the supply chain to minimise the billions lost in post-harvest logistics.View on euronews
Screening highlights legacy of Utica’s Old Main
A new documentary explores the history of Utica’s Old Main asylum, with a local screening drawing a full audience at the Oneida County History Center.
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / January 9, 2026 / RedChip Companies will air interviews with Alliance
Utica Ice Rink Closed January 23–25 Due to Winter Storm
The outdoor ice skating rink on the Parkway will be closed for several days due to expected frigid temperatures and a winter storm.
NextCure Provides Business Update
SIM0505 (CDH6 ADC) Phase 1 dose escalation data update anticipated in Q2 2026LNCB74 (B7-H4 ADC) Phase 1 dose escalation expanded into higher dose cohorts BELTSVILLE, Md., Jan. 23, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, today provided updates for its two antibody drug conjugate (ADC) programs and reported a preliminary year-end 2025 cash position. SIM0505 (CDH6 ADC): Phase 1 dose e
Takeda inks big expansion at former Motorola Mobility campus
The pharmaceutical giant is beefing up its distribution space at Innovation Park Lake County, a win for the Chicago developer that bought it just more than a year ago.
Utica's Sticker Project Engages Residents and Promotes Local Business
A creative sticker project is bringing new energy and pride to Utica while connecting residents with local businesses.
JPM26: Chugai chases new science and name recognition from US biopharma industry
The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. | The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. Morgan Healthcare Conference in San Francisco, they’re working hard to change that while also seeking out new science to bring into their storied drug discovery operation.
3SBio Sees More Business Development Deals
Tony He, CFO of the Chinese biopharmaceutical firm 3SBio, discusses his outlook for dealmaking and the progress of a record licensing deal the company struck with Pfizer last year. He speaks on “Bloomberg: The China Show” from San Francisco, where the JPMorgan Healthcare Conference is taking place. (Source: Bloomberg)
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / January 9, 2026 / RedChip Companies will air interviews with Alliance
Health Care Roundup: Market Talk
Find insight on China’s biopharmaceutical companies in the latest Market Talks covering the health care sector.
The Weight-Loss Drug Revolution—From Shots to Pills and the Science behind It All
Behind the hype of GLP-1 medications lies complex science, serious side effects and a pharmaceutical arms race.
Preparation Begins for Utica's Downtown New Year's Eve Party
The City of Utica is gearing up for its annual Bank of Utica New Year's Eve event.
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and...
Mohawk Valley high school sports schedule, scores for December 22-28
Results and highlights for Mohawk Valley high school sports competition during the week of December 22-28, 2025.
Trump announces deals with nine drug companies, aiming to lower cost of medicine
In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.
Trump secures agreements with major drugmakers to lower Medicaid prescription costs for Americans
President Donald Trump announced Friday that nine additional pharmaceutical companies joined its most-favored-nation pricing initiative.
Vertex Forward: Our animated video series
Watch the animated video series “Vertex Forward” to see the Vertex Pharmaceuticals philosophy and strategy explained.
Insmed Provides Clinical and Business Update
/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...
Insmed Provides Clinical and Business Update
Insmed Incorporated (Nasdaq:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, announced today that the Phase 2b BiRCh study of brensocatib in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) did not meet its primary or secondary efficacy endpoints in either the 10 mg or 40 mg treatment arms. Brensocatib was well tolerated, with no new safety signals identified
Holow Knight: Silksong - Sea of Sorrow DLC revealed
Holow Knight: Silksong has just revealed brand new DLC, which is known as Sea of Sorrow. Team Cherry is prepping it for a 2026 debut. Sea of Sorrow will feature new areas, bosses, tools, and more. Team Cherry teases: “Hornet’s adventures continue in our nautically themed expansion, coming free for all players next year. We’ll keep further details a secret...
How NIH-Funded Science Supports US Biopharmaceutical Innovation
NIH-funded research supports the foundation for industry to develop vaccines and therapies, exemplifying deep public-private R&D complementarity. As global competition intensifies, expanding NIH funding will be key to protecting American health, supporting U.S. biopharmaceutical competitiveness, and ensuring national power and security.
SPONSORED Novartis makes $23 billion investment in America's health
Ten facilities – including seven new sites – will create thousands of jobs and accelerate U.S. pharmaceutical innovation.
Holland & Knight Health Dose: December 3, 2025 | Insights
The Trump Administration finalized a trade agreement with the UK that exempts British-origin pharmaceuticals, ingredients and medical technology from Section 232 tariffs.
Opterion Health AG Announces Appointment of Andreas Schuh as Chief Financial Officer
MUTTENZ, Switzerland, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company pioneering innovation in peritoneal dialysis (PD), is pleased to announce the appointment of Andreas Schuh as Chief Financial Officer (CFO), effective December 1, 2025. Andreas Schuh joins Opterion with over 20 years of leadership experience across biotech, pharma, and medical devices. He has held senior finance and operations roles at Nuclidium, Jeito, Roivant, Novartis, and Al